Advertisement

U.S. markets open in 8 hours 21 minutes

S&P Futures
4,588.00
-1.50(-0.03%)
Dow Futures
36,174.00
+8.00(+0.02%)
Nasdaq Futures
16,017.25
-21.50(-0.13%)
Russell 2000 Futures
1,870.80
+1.10(+0.06%)
Crude Oil
70.62
+1.28(+1.85%)
Gold
2,046.40
0.00(0.00%)

Advertisement

Blueprint Medicines Corporation (0HOJ.L)

LSE - LSE Delayed Price. Currency in USD

74.36

+2.75

(+3.85%)

At close: 06:37PM GMT

Loading interactive chart...

Zacks
Why Is Gilead (GILD) Up 1.9% Since Last Earnings Report?
Gilead (GILD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Gen Digital (GEN) Up 14.6% Since Last Earnings Report: Can It Continue?
  Zacks
- American Equity (AEL) Up 3% Since Last Earnings Report: Can It Continue?
  Zacks
Zacks
Why Is Axsome (AXSM) Up 8.7% Since Last Earnings Report?
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PR Newswire
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective December 1, 2023, the Compensation Committee of Blueprint Medicines' Board of Directors granted non-qualified stock options to purchase an aggregate of 2,503 shares of its common stock and an aggregate of 1,251 restricted stock units (RSUs) to two new employees under Blueprint Medicines' 2020 Inducement Plan.